HUP0900482A2 - Pharmaceutical formulation for oral administration - Google Patents
Pharmaceutical formulation for oral administrationInfo
- Publication number
- HUP0900482A2 HUP0900482A2 HU0900482A HUP0900482A HUP0900482A2 HU P0900482 A2 HUP0900482 A2 HU P0900482A2 HU 0900482 A HU0900482 A HU 0900482A HU P0900482 A HUP0900482 A HU P0900482A HU P0900482 A2 HUP0900482 A2 HU P0900482A2
- Authority
- HU
- Hungary
- Prior art keywords
- oral administration
- pharmaceutical formulation
- formulation
- pharmaceutical
- oral
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0900482A HUP0900482A2 (en) | 2009-08-03 | 2009-08-03 | Pharmaceutical formulation for oral administration |
MX2012001461A MX2012001461A (es) | 2009-08-03 | 2010-08-02 | Preparacion farmaceutica, de administracion oral, que contiene insulina. |
UAA201202346A UA106506C2 (uk) | 2009-08-03 | 2010-08-02 | Інсулінвмісний фармацевтичний препарат для перорального застосування |
CN201080038764XA CN102791282A (zh) | 2009-08-03 | 2010-08-02 | 可口服给予的含有胰岛素的药物制剂 |
EP10757272A EP2461820A1 (en) | 2009-08-03 | 2010-08-02 | Orally administerable pharmaceutical preparation containing insulin |
PCT/IB2010/053499 WO2011015984A1 (en) | 2009-08-03 | 2010-08-02 | Orally administerable pharmaceutical preparation containing insulin |
CA2769620A CA2769620A1 (en) | 2009-08-03 | 2010-08-02 | Orally administerable pharmaceutical preparation containing insulin |
JP2012523416A JP2013501043A (ja) | 2009-08-03 | 2010-08-02 | 経口投与可能な医薬製剤 |
KR1020127005524A KR20120088660A (ko) | 2009-08-03 | 2010-08-02 | 경구투여가능한 인슐린 함유 약제학적 조성물 |
US13/387,212 US20120129769A1 (en) | 2009-08-03 | 2010-08-02 | Orally administerable pharmaceutical preparation containing insulin |
AU2010280418A AU2010280418B2 (en) | 2009-08-03 | 2010-08-02 | Orally administerable pharmaceutical preparation containing insulin |
BR112012002413A BR112012002413A2 (pt) | 2009-08-03 | 2010-08-02 | preparação farmacêutica administrável oralmente contendo insulina |
RU2012109006/15A RU2012109006A (ru) | 2009-08-03 | 2010-08-02 | Инсулинсодержащий фармацевтический препарат для перорального применения |
IL217856A IL217856A0 (en) | 2009-08-03 | 2012-01-31 | Orally administerable pharmaceutical preparation containing insulin |
ZA2012/01519A ZA201201519B (en) | 2009-08-03 | 2012-02-29 | Orally administerable pharmaceutical preparation containing insulin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0900482A HUP0900482A2 (en) | 2009-08-03 | 2009-08-03 | Pharmaceutical formulation for oral administration |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0900482D0 HU0900482D0 (en) | 2009-10-28 |
HUP0900482A2 true HUP0900482A2 (en) | 2011-03-28 |
Family
ID=89989155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0900482A HUP0900482A2 (en) | 2009-08-03 | 2009-08-03 | Pharmaceutical formulation for oral administration |
Country Status (15)
Country | Link |
---|---|
US (1) | US20120129769A1 (hu) |
EP (1) | EP2461820A1 (hu) |
JP (1) | JP2013501043A (hu) |
KR (1) | KR20120088660A (hu) |
CN (1) | CN102791282A (hu) |
AU (1) | AU2010280418B2 (hu) |
BR (1) | BR112012002413A2 (hu) |
CA (1) | CA2769620A1 (hu) |
HU (1) | HUP0900482A2 (hu) |
IL (1) | IL217856A0 (hu) |
MX (1) | MX2012001461A (hu) |
RU (1) | RU2012109006A (hu) |
UA (1) | UA106506C2 (hu) |
WO (1) | WO2011015984A1 (hu) |
ZA (1) | ZA201201519B (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2726091T3 (pl) * | 2011-06-29 | 2020-08-10 | Rani Therapeutics, Llc | Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek |
US20200126671A1 (en) * | 2017-06-28 | 2020-04-23 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Method for determining the risk to develop type 1 diabetes |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172814A (en) | 1962-04-06 | 1965-03-09 | Jr Edgar A Ferguson | Oral blood sugar lowering compositions |
JPS5428807A (en) | 1977-08-09 | 1979-03-03 | Hiroyuki Sumi | Oral insulin |
IL68769A (en) * | 1983-05-23 | 1986-02-28 | Hadassah Med Org | Pharmaceutical compositions containing insulin for oral administration |
ES2045276T3 (es) | 1988-07-21 | 1994-01-16 | Hoffmann La Roche | Preparacion de insulina |
CA2125284C (en) | 1991-12-05 | 2000-06-20 | Jens-Christian Wunderlich | Peroral administration form for peptidic medicaments, in particular insulin |
JP3047948B2 (ja) * | 1992-12-07 | 2000-06-05 | 株式会社ツムラ | ペプチド類経鼻投与用組成物 |
US5359030A (en) | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
US5968899A (en) * | 1994-06-03 | 1999-10-19 | Tsumura & Co. | Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption |
US5461031A (en) * | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
US5653987A (en) | 1995-05-16 | 1997-08-05 | Modi; Pankaj | Liquid formulations for proteinic pharmaceuticals |
US5970193A (en) | 1996-10-24 | 1999-10-19 | Nortel Networks Corporation | Data communications structures relating to data shelf configurations |
NZ500075A (en) | 1997-04-02 | 2001-03-30 | Purdue Research Foundation | Method for the oral delivery of a protein encapsulated within a hydrogel matrix |
CN1329502A (zh) | 1998-12-04 | 2002-01-02 | 普罗瓦利斯英国有限公司 | 含有胰岛素的药物组合物 |
US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
PT1454630E (pt) | 2003-03-04 | 2010-12-15 | Technology Dev Company Ltd | Composição de insulina injectável de acção prolongada e métodos para o seu fabrico e utilização |
JP5103748B2 (ja) * | 2005-02-16 | 2012-12-19 | 東レ株式会社 | 医薬組成物 |
EP2722054B1 (en) * | 2005-09-06 | 2018-03-21 | Oramed Pharmaceuticals Inc. | Methods and compositions for oral administration of proteins |
US8927015B2 (en) | 2006-04-12 | 2015-01-06 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
CN101062408B (zh) * | 2006-04-27 | 2010-12-08 | 深圳市隆阳生物科技有限公司 | 口服胰岛素复合制剂及其制备方法 |
JP2008266179A (ja) * | 2007-04-19 | 2008-11-06 | Fujifilm Corp | 経肺用組成物 |
EP2164466A1 (en) * | 2007-06-01 | 2010-03-24 | Novo Nordisk A/S | Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier |
NZ591497A (en) * | 2008-08-18 | 2012-11-30 | Entera Bio Ltd | A compositions comprising a protein, a protease inhibitor and N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC) or N-(10[2-hydroxybenzoyl]amino)decanoate (SNAD) for diabetes mellitus treatment |
-
2009
- 2009-08-03 HU HU0900482A patent/HUP0900482A2/hu unknown
-
2010
- 2010-08-02 EP EP10757272A patent/EP2461820A1/en not_active Withdrawn
- 2010-08-02 BR BR112012002413A patent/BR112012002413A2/pt not_active IP Right Cessation
- 2010-08-02 WO PCT/IB2010/053499 patent/WO2011015984A1/en active Application Filing
- 2010-08-02 RU RU2012109006/15A patent/RU2012109006A/ru unknown
- 2010-08-02 MX MX2012001461A patent/MX2012001461A/es not_active Application Discontinuation
- 2010-08-02 KR KR1020127005524A patent/KR20120088660A/ko not_active Application Discontinuation
- 2010-08-02 AU AU2010280418A patent/AU2010280418B2/en not_active Expired - Fee Related
- 2010-08-02 CA CA2769620A patent/CA2769620A1/en not_active Abandoned
- 2010-08-02 US US13/387,212 patent/US20120129769A1/en not_active Abandoned
- 2010-08-02 CN CN201080038764XA patent/CN102791282A/zh active Pending
- 2010-08-02 UA UAA201202346A patent/UA106506C2/uk unknown
- 2010-08-02 JP JP2012523416A patent/JP2013501043A/ja active Pending
-
2012
- 2012-01-31 IL IL217856A patent/IL217856A0/en unknown
- 2012-02-29 ZA ZA2012/01519A patent/ZA201201519B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20120088660A (ko) | 2012-08-08 |
AU2010280418A1 (en) | 2012-03-22 |
RU2012109006A (ru) | 2013-09-10 |
UA106506C2 (uk) | 2014-09-10 |
AU2010280418B2 (en) | 2015-04-09 |
EP2461820A1 (en) | 2012-06-13 |
JP2013501043A (ja) | 2013-01-10 |
ZA201201519B (en) | 2013-05-29 |
MX2012001461A (es) | 2012-05-22 |
IL217856A0 (en) | 2012-03-29 |
US20120129769A1 (en) | 2012-05-24 |
WO2011015984A1 (en) | 2011-02-10 |
CA2769620A1 (en) | 2011-02-10 |
BR112012002413A2 (pt) | 2016-03-01 |
CN102791282A (zh) | 2012-11-21 |
HU0900482D0 (en) | 2009-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201101523B (en) | Linaclotide-containing formulations for oral administration | |
HK1164059A1 (en) | Compositions for drug administration | |
IL218928A (en) | Corticosteroids for oral administration | |
HK1169960A1 (en) | Pharmaceutical formulation | |
EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
IL211099A0 (en) | Formulation for oral administration of proteins | |
ZA201105572B (en) | Pharmaceutical composition for oral administration | |
ZA201100615B (en) | Appetising medicament for oral administration in solid form | |
EP2263637A4 (en) | MEDICINAL PREPARATION FOR ORAL ADMINISTRATION | |
EP2456439A4 (en) | STABLE PHARMACEUTICAL OMEPRAZOLE FORMULATION FOR ORAL ADMINISTRATION | |
EP2206519A4 (en) | MEDICINAL PREPARATION FOR ORAL ADMINISTRATION | |
EP2407162A4 (en) | COMPOSITION FOR ORAL ADMINISTRATION | |
PL2253326T3 (pl) | Kompozycja farmaceutyczna do podawania przeznosowego | |
HUE040419T2 (hu) | Analgetikus gyógyászati kompozíció orális beadásra | |
HUP0900482A2 (en) | Pharmaceutical formulation for oral administration | |
EP2520300A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
ZA201102405B (en) | Pharmaceutical composition for oral administration | |
EP2529755A4 (en) | PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION | |
EP2474294A4 (en) | PREPARATION FOR ORAL ADMINISTRATION | |
EP2473168A4 (en) | PHARMACEUTICAL FORMULATIONS FOR INDIBULIN | |
IL219860A0 (en) | Oral formulation for dexlansoprazole | |
GB0906003D0 (en) | Oral drug formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |